A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

A single, oral dose of rimegepant offered superior relief as soon as 2 hours post-dose compared with placebo in patients with ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

Four already-approved drugs eased pain and shrank lesions in mice. Doctors share what that could mean for you.

AbbVie's atogepant showed fewer side effects and greater efficacy than topiramate in a Phase 3 migraine prevention trial.

H. Lundbeck A/S (Lundbeck) today announced the full results from the phase IV RESOLUTION trial. The trial was a randomized, placebo-controlled trial designed to evaluate the efficacy of eptinezumab ...

GLP-1 agonists have gained recent widespread attention, reshaping treatment approaches for several diseases, including diabetes and cardiovascular disease. 2 In the treatment of type 2 diabetes, ...

The trial judged the tolerability, safety and efficacy of atogepant, at 60 milligrams once daily, compared to the ...

Lundbeck US, the US subsidiaries of H. Lundbeck A/S, today announced it will present one oral and eight poster presentations at the 67th Annual Scientific Meeting of the American Headache Society (AHS ...

Speed 00:01 00:00 Shades for Migraine campaign raises awareness about a disease that affects millions. (WJAR) Raising awareness is crucial. That's where the Association of Migraine Disorders plays a ...